On the morning of September 23, the 2015 Shenzhen International BT leaders summit was held at the Dujuan hall on the 5th floor of Shenzhen Exhibition center. Renowned experts, scholars and entrepreneurs in the fields of biology and life health at home and abroad gathered to discuss the way forward for the development of the industry.

This BT leaders summit has carefully designed three major keynote speeches, two high-end dialogues, eight professional forums and other key activities.

The two high-end dialogues are respectively " opportunities and challenges in the era of precision medicine" and " bio-medicine, medical technology and equipment supervision policy". They are chaired by Chen Youhai, the chief scientist of the advanced institute and a life-long professor of the University of Pennsylvania, and Lu Xianping, the president of CHIPSCREEN BIOSCIENCES. They discuss the development prospect of bio-medicine and the hot issues in the development of bio-medicine, medical technology and equipment supervision at home and abroad with many distinguished guests, and set up exchange platforms for academic discussions, industrial transformation cooperation and policy discussions.

The first high-end dialogue focused on the theme of " opportunities and challenges in the precision medical era" to discuss the current situation of the development of the health industry in the precision medical era, how to grasp the opportunities, meet new challenges, and promote the development of precision medical treatment technology and clinical transformation and application.

The second high-end dialogue was presided over by Lu Xianping, the president of CHIPSCREEN BIOSCIENCES, Feng yi, the assistant director of the China Food and Drug Administration Drug Review Center, Peng Jian, the executive member of the clinical oncology collaboration professional Committee of the Chinese Anti-cancer Association, Li Yongguo, the vice-president of China Pharmaceutical Technology ( Shanghai ) co., ltd., Wang Baoting, the deputy secretary-general of the China Pharmaceutical Supervisory and Management Research Association, Zhu Xun, the president of the New Drug Excellence Club, David J Dikeman, the partner of the American Greenberg Traurig law firm and co-chairman of the life sciences and medical technology group. They exchange views, discuss opportunities and challenges of biomedicine, medical technology and equipment industry and new progress in industry development under the new situation through specific cases, jointly study hot issues in the development of biomedicine, medical technology and equipment supervision at home and abroad, discuss policies and measures to speed up the development of industry, and build a comprehensive platform for promoting the development of global biomedicine, technology and industry such as academic exchange, industrial cooperation and policy discussion.